
    
      Approximately 400 subjects aged 4-17 years and older with type 1 or type 2 diabetes, who
      require daily blood glucose monitoring to manage their diabetes will be enrolled in the
      study. Subjects and/or their caregivers will utilize capillary SMBG for managing diabetes for
      6 months. Subjects and/or their caregivers will maintain a diary/log book of Adverse Events
      experienced during the duration of the study. Assessment of Adverse Events will occur via
      self reporting at each monthly visit and/or phone call.
    
  